Wednesday, 29 April 2020

Agriculture Drones Market Manufacturers, Regions, Type and Application, Forecast to 2026

According to a new report published by Polaris Market Research, the worldwide agriculture drones market is anticipated to reach around USD 8,019.8 million by 2026. In 2017, the field mapping segment dominated the global market, in terms of revenue. North America is expected to be the leading contributor to the global market in 2017.

There has been an increasing adoption of agricultural drones across the world owing to growing agricultural industry, and high-demand for high quality food crops. The growing use of drones for crop health monitoring, weed detection, variable rate application, crop scouting, and livestock management supports the agriculture drones market growth. The growing population and increasing automation of farm operations further supports agriculture drones market growth. The global agricultural drones market is driven by the increasing need to improve the quality of crops produced, maximize crop production, and enhance productivity. Other factors driving the growth of this market include growth in the global agricultural industry, reducing availability of labors, and increasing labor costs. However, safety, security, and privacy concerns restrict the growth of the agricultural drones market. Growing demand from emerging economies, and technological advancements are factors expected to provide numerous growth opportunities in the coming years.


According to the United States Department of Agriculture, National Agriculture Imagery Program (NAIP) utilizes drones with camera and sensor payloads to develop digital orthophotographs. These images are available to the government agencies and general public for estimation of land usage, crop plantings and yields, and others. In March 2016, Agribotix LLC partnered with Inter-American Institute for Cooperation on Agriculture (IICA) to introduce agriculture drone and data analytics for crop health management and improvement of agriculture production.


North America generated the highest revenue in the market in 2017. The increasing population, and growing demand for high quality crops drives the growth of this market. Growing cost of labor and increasing automation in agricultural practices further support global agriculture drones market growth. Increasing investments and subsidies in the agriculture sector by governments are expected to boost the adoption of drones for increased productivity in farms.


The different components used in agriculture drones include hardware, software, and services. In 2017, the hardware segment accounted for the largest share in the global market. The hardware used in agricultural drones include technologically advanced cameras, navigation systems, frames, controllers, propulsion systems, and others. The hardware components are required for capturing information and monitoring of fields and crops.

The well-known companies profiled in the report include Trimble Navigation Limited, DJI Technology Co., Ltd, Parrot SA, Drone Deploy, Agribotix LLC, Honeycomb Corporation, Aerovironment, Inc., Eagle UAV Services LLC, 3D Robotics Inc., AgEagle Aerial Systems, Inc., Autocopter Corp, and Ursula Agriculture. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.

Contact us

Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com
on No comments:
Labels: , , ,

Friday, 24 April 2020

Apheresis Equipment Market Growth Opportunities to Tap into in 2020-2026

The global apheresis equipment market is anticipated to reach over USD 5,351.17 Million by 2026 according to a new research published by Polaris Market Research

An apheresis apparatus is a device which collects blood that is detached from a donor’s or patient’s body and splits up it into its several constituents such as red blood cells, platelets, plasma, and white blood cells. Depending on the purpose for apheresis, one of these constituents is collected and isolated by the equipment, while the others components are reverted to the body.

Polaris Market Research’s report on apheresis equipment market spans more than 90 pages and includes more than 70 tables and figures. Browse the detailed table of contents for, “By Procedure Type (Plasmapheresis, Plateletpheresis, Leukapheresis, Lymphopheresis, Erythrocytapheresis); By Application (Blood Donation, Therapeutic Purpose); By End User (Hospitals, Clinics, Ambulatory Surgical Centers, Blood Donation Centers); By Regions (North America – U.S., Canada; Europe – Germany, UK, France, Italy, Russia; Asia-Pacific – China, India, Japan, Australia; Latin America – Brazil, Mexico; Middle East & Africa – UAE, Saudi Arabia, South Africa)]: Market size & Forecast, 2017 – 2026” on 


Some major key players in global apheresis equipment market include Haemonetics Corporation, Fresenius Kabi (Fenwal), Asahi Kasei Kuraray Medical Co. Ltd., Terumo BCT, Inc., HemaCare Corporation, Therakos, Inc. and B. Braun Melsungen AG among others.

Rising occurrence of blood-related ailments leading to the increase in demand for plasma and platelets is expected to serve the market as a high influence rendering driver. Moreover, the apheresis equipment market is driven by advancement in technology intended at delivering comparatively more rapid and effective results. Healthcare experts and researchers are now in the need for instruments that require minimum human involvement and institution of fully automatic apheresis equipment with improved displays is anticipated to augment the usage rates further bolstering the market growth.

The global apheresis equipment market is segmented on the basis of procedure type, application, end user, and geography. On the basis of procedure type, the global Apheresis Equipment Market is segmented into Plasmapheresis, Plateletpheresis, Leukapheresis, Lymphopheresis, and Erythrocytapheresis. In 2017, the Plasmapheresis is estimated to dominate the market growth. Increasing occurrence of blood-related diseases and rising demand for plasma-derived drugs are anticipated to serve as a primary growth driver of this segment. On the basis of application, the global apheresis equipment market is segmented into Blood Donation and Therapeutic Purpose. The therapeutic purpose is further categorized into Renal, Hematology, and Other Rare Diseases. On the basis of the end user, the global apheresis equipment market is segmented into hospitals, clinics, ambulatory surgical centers, and blood donation centers. On the basis of end users, the hospital segment is anticipated to dominate the market growth in 2017.


On the basis of region, the global apheresis equipment market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America was projected to dominate the global apheresis equipment market. The domination is majorly owing to growing healthcare spending, the existence of a high number of market players, high donor awareness levels, and relatively higher number of Research & Development movements concerning to product manufacturing and marketing accomplishments in this region. However, Asia Pacific is expected to dominate the global apheresis equipment market. Growing amount of diverse types hematological ailments in this region is the major factor boosting the growth of apheresis equipment market during the forecast period.


Contact us
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com
on No comments:
Labels: , , ,

Transcatheter Aortic Valve Replacement Market Report is best solution to Growing Economical Trend by 2020-2025

The global transcatheter aortic valve replacement (TAVR) market is anticipated to reach USD 8,241.4 Million by 2025 according to a new study published by Polaris Market Research.

Transcatheter aortic valve replacement (TAVR), known as transcatheter aortic valve implantation (TAVI) the surgical procedure for heart disease wherein transcatheter heart valve is used to replace the damaged as well as old heart valve. Transcatheter heart valve implantation is a minimally invasive process that helps in substituting the damaged heart valve with a prosthetic valve for treatment of mitral regurgitation and unembellished aortic stenosis. Transcatheter aortic valve replacement procedure that helps to diminish severe degenerative aortic stenosis and increases the survival rate of patients.



The global Transcatheter Aortic Valve Replacement (TAVR) Market is driven by factors such as growing number of the patient pool with cardiovascular ailments such as coronary artery diseases, heart failures, and hypertension. According to World Health Organization (WHO), the number of people suffering cardiovascular disorders will surge to 22.2 million by 2030 globally. Moreover, rising implementation of minimally intrusive processes over traditional surgical open-heart procedures, reduction in hospital stays, low risk of infection, minimal blood loss is further propelling the market. Moreover, increase in occurrence of aortic stenosis disorders coupled with rise in elderly population, evolution in implementation rate of transcatheter aortic valve implantation procedure owing to high demand for minimally invasive procedures, an increase in medical and clinical indication of safety & efficacy and new products approvals are other factors propelling the global Transcatheter Aortic Valve Replacement (TAVR) Market growth.
  
The global transcatheter valve replacement (TAVR) market is segmented on the basis of surgical procedure, end user, and geography. On the basis of surgical procedure, the global transcatheter valve replacement (TAVR) market is categorized into Transfemoral (TF) Implantation, Transapical (TA) Implantation, and Transaortic Implantation. The global market by the surgical procedure is dominated by Transfemoral (TF) Implantation majorly due to growing focus on tentative products by key players which are estimated to boost the market growth of transcatheter valve replacement (TAVR) market globally. Moreover, Transfemoral implantation is the standardized as well as consistent TAVR procedure, in which an artificial valve is inserted through the femoral blood vessel with the minimally invasive procedure and negligible anesthesia. Thus, the transferomal (TF) implantation segment accounted for the highest market share in 2017 and is anticipated to preserve the governance during the forecast period.


Based on the end users, the global transcatheter aortic valve replacement (TAVR) market is further categorized into hospitals, ambulatory surgical centers, and cardiac catheterization laboratory. The Hospital segment is expected to show the highest market growth over the forecast period. Growing patient pool and rising demand for efficient and effective surgical process with shorter recovery time and reduced hospital stay are the key factors driving the market shares for hospitals in global transcatheter aortic valve replacement (TAVR) market.

Some of the major key players operating in global Transcatheter Aortic Valve Replacement (TAVR) Market are Boston Scientific Corporation, Direct Flow medical, Inc., Edwards Lifesciences Corporation, HLT, Inc., JenaValve Technology, Inc., Medtronic plc, Meril Life Sciences Pvt. Ltd., St. Jude Medical, Inc., SYMETIS SA, and Transcatheter Technologies GmbH among others.


Contact us
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com


on No comments:
Labels: , ,

Sepsis Diagnostics Market is anticipated to reach over USD 1033.02 Million by 2026

Sepsis diagnostics market is anticipated to reach over USD 1033.02 Million by 2026 according to a new study published by Polaris Market Research.

Sepsis is a type of fatal organ dysfunction ailment rises when the body responses to an infection to its own organs and tissues and organs. This disorder can be triggered due to the weakened immune system, kidney or liver disease, chronic illness such as cancer, and severe wounds. Sepsis can be of two types septic shock in which there are the indications of severe sepsis including a low blood pressure and another is severe sepsis when there’s organ failure.


The high occurrence of people suffering sepsis and the demand for appropriate diagnosis and treatment is anticipated to bolster the demand for the sepsis diagnostics market. In addition, rising number of hospital-acquired infections (HIA) are expected to support the growth of the market during the forecast period. Hospital-acquired infections primarily include surgical site and urinary tract infections, which result in sepsis. According to the World Health Organizations (WHO), 7 out of every 100 hospitalized patients develop hospital-acquired infections in developed economies. This, in turn, demands proper diagnosis, further bolstering the market growth. On the other hand, pneumonia is also a significant driving factor for the high demand of sepsis diagnostics market as it is one of the major causes of septic shock.
  
The global Sepsis Diagnostics Market is segmented on the basis of products, technology, pathogen, testing type, and geography. On the basis of products, the global Sepsis Diagnostics Market is segmented into Instruments, Blood Culture Media, and Assay Kits and Reagents. In 2017, the blood culture media was projected to be the major market sharing segment during the forecast period. The cost-effectiveness mode of the test is the primary reason for the major market share. In addition, due to the lower cost, the blood culture method is also considered as the gold standard method. On the basis of technology, the global sepsis diagnostics market is segmented into Microbiology, Molecular Diagnostics, Immunoassays, and Flow Cytometry. 




The microbiology segment was estimated to be the dominating segment due to the fact that it permits the identification and quantitative detection of microbes for sepsis diagnosis through the application of culture media tests. On the basis of the pathogen, the global sepsis diagnostics market is segmented into Bacterial Sepsis and Fungal Sepsis. The bacterial sepsis id further categorized into, gram-positive bacteria and gram-negative bacteria. In 2017, the bacterial sepsis segment is anticipated to dominate the segment. This is due to the patients suffering from the blood poisoning disease is a generally considered as a casualty of bacterial infection. On the basis of test type, the global sepsis diagnostics market is segmented into Laboratory Testing and PoC Testing. In 2017, the laboratory testing type is estimated to dominate the market.

Some major key players in global Sepsis Diagnostics Market include Becton, Dickinson and Company, bioMérieux SA, Roche Diagnostics, Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Cepheid Inc., Bruker Corporation, and Nanosphere, Inc. among others.


Contact us
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com




on No comments:
Labels: , ,

Constrained Layer Damping Market Historical Growth, Regional Trends, Forecast 2026

The global Constrained Layer Damping (CLD) market is anticipated to reach USD 1,160 million by 2026 according to a new study published by Polaris Market Research.

Global constrained layer damping market is expected to grow significantly over the forecast period from 2018 to 2026 owing to numerous advancements that is driven by a strong growth in various application industries such as automotive, aerospace, defense and construction. Their ability to subdue noise and vibrations generating between the connection of metal or plastic parts is expected to boost the market for constrained layer damping during the forecast period from 2018 – 2026. Constrained layer damping are forms of shear-related energy dissipation systems accomplished by interlocking two or more physical materials using a relatively thin viscoelastic layer. Some of the benefits of using constrained layer dampening systems for dealing with damping of noise and vibrations are the capability to attain high loss factors with comparatively thin configurations and that the rigidity of the composite system is not evidently increased. The systematic technological development of constrained layer damping is expected to be witnessed throughout the forecast period from 2018 – 2026.


The market for constrained layer damping is segmented on the basis of type into active and passive constrained layer damping. Passive constrained layer damping (PCLD) is a recognized technique to add damping to a system. PCLD is a facade damping treatment that consists of more than one viscoelastic layer and one or more non-actuated coerced layer. These PCLD systems are installed to the base layer, the layer that presents the unwanted resonance or vibration. However passive constrained layer damping systems has been replaced by active constrained layer damping (ACLD). This technology can be described as a failsafe, smart and efficient noise and vibration attenuation technology over a large frequency band. The market is also further segmented by viscoelastic material which includes butyl, vinyl, polyurethane and others. On the other hand, the constrained layer damping is additionally segmented into product type into aluminum, steel, non-metallic and others. The steel product type is expected to account for a lion share in the market owing to its application various industries. Steel along with composites have a superior damping capability to reduce structure-borne noise. Furthermore, on the basis of end-use industry the constrained layer damping market into automotive, aerospace, marine, electronics, construction and others. According to Polaris Market Research analysis, automotive end-use industry is expected to dominate the constrained layer damping market.


The future prospect of constrained layer damping looks promising due to the factors such as rising vehicle production coupled with advancing technologies for attaining NVH levels in the automotive industry is expected to drive the market over the forecast period. Additionally, trends in the construction industry to isolate noise and vibrations from structure is expected to fuel the market.

Asia Pacific was the largest regional market in 2017 and it is expected to retain its position during the forecast period. The region is anticipated to account for the maximum share of the overall worldwide market in terms of constrained layer damping systems. China being the largest production hub of automotive vehicle around the world is the major reason for the region’s stellar performance as the automotive industry holds the prime market share in the constrained layer damping market. Additionally, countries such as Japan, South Korea and India is further adding up to the growth of the total market.

Some of leading industry participants include Trelleborg AB, Nitto Denko Corporation, Pyrotek Inc., Sika AG, American Acoustical Products, Megasorber Pty Ltd, Vibratec, Autoneum, Henkel Ltd., Flexcon Company, Inc, Rousch, Avery Dennison Corporation, Heathcote Industrial Plastics, Soundown Corporation, Vibracoustic Gmbh, Polymer Technology Inc., and 3M among others.


Contact us
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com
on No comments:
Labels: , , ,

Ceramic Membrane Market 2020 Analytical Overview, Growth Factors, Demand and Trends by 2026

The global Ceramic Membrane market size is expected to reach USD 15,900.1 million by 2026 according to a new study by Polaris Market Research

Ceramic membranes are being used in high value applications such as protein fractionation in dairies, cell harvesting, separation of flow streams among others. Ability to withstand extreme pH conditions as well as to operate under extreme temperature ranges are some of the factors benefitting the market growth. Properties of ceramic materials such as inertness, longer service life, reliability, heat resistance, backflush capability, regenerative capacity, resistance to acids, alkalis are being effectively used by companies and have developed superior ceramic membrane filtration systems that find applications in a wide range of industries ranging from chemicals to water treatment.


Companies operating in this market have developed products that have low flow resistance while in turn delivering high mechanical as well as chemical stability. They have also made metallurgical strides and now use a combination of manufacturing materials to produce quality and superior product. Advancements in manufacturing processes have enabled manufacturers of ceramic membranes to have better control over various ceramic membrane aspects such as layer texture, porosity, among others. Such trends have resulted in the serving of customized needs of high value applications such as premium food products, pharmaceuticals, etc. and this trend has benefitted the overall market growth.

From an expensive, stringent, and difficult to use product, due to the continuous R&D efforts, these membranes have evolved into a sustainable and robust technology that can be effectively use to obtain clean water. Water & wastewater treatment industry is increasingly adopting these membranes due to inherent advantages such as 100% integrity into process, high operating temperature and pressure range, foul resistant, and ability to back rinsing. Water scarcity across the globe, rising population, initiatives taken by governments and world agencies to ensure clean water access to all are fueling water treatment market growth and this trend is in turn anticipated to contribute to ceramic membrane demand for water treatment applications.


The North American market is dominated by major players in the region influencing the overall supply chain. In addition, environmental standards related to minimizing of energy usage will drive the product growth offering low cost water treatment. Presence of key universities in the regions focusing on water treatment technologies are the key factor for regional competition. Product innovation and acquisitions are among the major strategies adopted by the players in the region.

Concentrated efforts are being taken to reduce the overall capital expenditure as well as operating expenditure of the ceramic membrane filtration systems. Such efforts have garnered attention of governments, as well as industry participants. Such concentrated efforts are expected to further reduce the overall ceramic membrane manufacturing, operational and maintenance costs. Companies such as TAMI Industries, A-tech innovation GmbH, Liqtech A/S, Saint Gobain, Qua Group LLC, Hyflux Limited, Nanostone Water Inc., GEA Group, Toray Industry Inc., Veolia Water Technologies, and Pall Corporation are some of the key players operating in the market


Contact us
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com
on No comments:
Labels: , , , ,

All-Terrain Vehicle & Utility Task Vehicle Market Regional Insights, Trends, Revenue & Forecast To 2026

The global ATV and UTV market generated $9.2 billion in 2017 and is anticipated to grow at a CAGR of 8.3% during the forecast period according to a new report published by Polaris Market Research.

All-terrain vehicles (ATV) are small, open, and single-seated motor vehicles with three or four tires. It has the ability to operate on a wide variety of terrains such as forests, mountains, snow, and other rough terrains. These vehicles have deep-threaded tires that enable the vehicles to be driven on rocky, muddy, and root cover terrains. Utility task vehicles are IC engines or electric motors powered vehicles driven through steering, and used in applications such as farming, mining, and rescue.


The demand for ATV and UTV has increased over the years owing to increasing tourism activities. The increasing trend of sports activities and adventure sports has increased the demand for these vehicles. The growing consumer disposable income and improving living standards also fuel the market growth. Other factors supporting the market growth include technological advancements, increasing applications in defense and agriculture sectors, and supportive government initiatives.

The report provides an extensive qualitative and quantitative analysis of the market trends and growth prospects of the Global ATV and UTV Market, 2017-2026. This report comprises a detailed geographic distribution of the market across North America, Europe, Asia-Pacific, Latin America, and MEA. North America is further segmented into U.S., Canada, and Mexico. Europe is divided into Germany, UK, Italy, France, and Rest of Europe. Asia-Pacific is bifurcated into China, India, Japan, and Rest of Asia-Pacific. North America generated the highest revenue in 2017 owing to increasing applications in agriculture, defense, and mining applications. The high disposable incomes, and government initiatives to promote sport activities have resulted in market growth in the region.

  
Competitive Landscape and Key Vendors
The global ATV and UTV market is characterized by the presence of well-diversified international and small and medium-sized vendors. These companies are consistently launching new products to enhance their offerings in the market. With the advancement of technologies, companies are innovating and introducing new customized products to cater the growing needs of the customers. Leading companies are also acquiring other companies, and enhancing their product offerings to improve their market reach. Acquisitions enable key players to increase their market potential in terms of geographic expansion and expansion of customer base.

The leading companies profiled in the report include Yamaha Motors, Honda Motors Co Ltd, Deere & Company, Polaris Industries, Kubota Corporation, Caterpillar Inc., Kawasaki Heavy Industries Motorcycle & Engine Company, Bobcat Company, Hisun Motors, and Bombardier Recreational Products.


Contact us
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com

on No comments:
Labels: , ,

Xerostomia Therapeutics Market Growth Factors, Regional Analysis, Applications, & Manufacturers and Forecasts

The global xerostomia therapeutics market size is expected to reach USD 822.1 million by 2026 growing at a CAGR of 3.6% during the forecast period according to a new report published by Polaris Market Research. The report “Xerostomia Therapeutics Market Size, Share, Trends, & Industry Analysis Report By Product (Dentifrices, Artificial Saliva, Saliva Substitutes, Salivary Stimulants, Drugs, and Salivary Pen); By Distribution Channel; By Regions: Segment Forecast, 2019 – 2026” provides an extensive analysis of present market dynamics and predicted future trends.

Xerostomia usually called as dry-mouth ailment which occurs due to missing or decreased saliva. Generally, xerostomia is not considered as a disease, yet it is a problem which occurs due to numerous clinical scenarios such as adverse effects of radioactivity on head and also neck usually due to radiation treatment and negative effects of a variety of drugs and it might or might not be always related to the reduced functionality of salivary glands. Xerostomia is a usual trouble majorly observed among senior citizens and it is estimated that it is impacting around 20% of the people around the globe. However, it is not an age-related problem as it is usually triggered as a side-effect of medication.



Increase in favorable compensation plans for xerostomia products as well as increasing responsiveness and awareness about diseases associated with the condition are some of the major factors driving the market growth. Increasing occurrences of xerostomia as well as relevant medical conditions such as Parkinson’s disease, high blood pressure, Sjogren’s disorder, as well as diabetes mellitus has an affirmative impact on the international market. According to Colgate-Palmolive Company, it is estimated that more than twenty-five million people in the United States have the dry mouth problem. Similarly, Sjogren Syndrome Foundation estimates that more than four million people are suffering from Sjogren’s condition which is one the syndrome which causes dry mouth. However, to curb this problem, this foundation runs awareness programs in the U.S. for the people who are suffering from this condition and also to educate the public in general. This factor has also helped to push the overall market in this region. Along with different foundations creating awareness among the people, many of the major pharma companies are working towards acquisitions and joint ventures with emerging companies to increase their product portfolio and to create awareness among the people, further pushing the overall market.
The global xerostomia therapeutics market report has been segmented by type, distribution-channel and region and it is anticipated that the market size was 625.3 million in 2018 and is estimated to grow at a CAGR of 3.6% from 2019 to 2026. The dentifrices market segment is expected to be the largest segment in 2018 due to its increased adoptability, reduced pricing and availability. This is closely followed by the salivary stimulants segment which is anticipated to have a high growth rate during the forecast period.


Under the distribution channel segment, hospital pharmacy segment dominated the market in terms of revenue in 2018. This was majorly due to ease of accessibility, availability of branded as well as generic medicines and reduced item prices. Regionally, North America is estimated to be the major region in 2018 followed by the European market. Increasing awareness among the people in these regions and initiatives taken by various foundations and companies are expected to push the market. Asia Pacific on other hand is expected to grow at a higher rate due to growing medical infrastructure and increased spending towards healthcare in developing countries such as India and China.

Some of the leading companies in this market include Colgate-Palmolive Company, Church & Dwight Co., Inc, EUSA Pharma, GlaxoSmithKline plc, Forward Science, Mission Pharmacal Company, Eisai Inc., OraHealth Inc., Parnell Pharmaceuticals, Inc., OraPharma, Inc, Saliwell Ltd., Dentaid, and Sun Pharmaceutical Industries Limited. 

Polaris Market Research has segmented the global xerostomia therapeutics market report on the basis of product type, distribution channel and region:

Xerostomia Therapeutics Product Type Outlook (Revenue, USD Million, 2016 – 2026)
  • Artificial Saliva
  • Dentifrices
  • Salivary Stimulants
  • Saliva Substitutes
  • Drugs
  • Salivary Pen
Xerostomia Therapeutics Distribution Channel Outlook (Revenue, USD Million, 2016 – 2026)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Contact us
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com
on No comments:
Labels: , , ,

Hematologic Malignancies Therapeutics Market CAGR Status, Industrial Analysis | Market Current Insights, Growth & Opportunities

The Global Hematologic Malignancies Therapeutics Market Size is anticipated to reach over USD 87.0 Billion by 2025 according to a new research published by Polaris Market Research. 
Hematological malignancy is a type of cancer that affect the bone marrow, blood, and lymph nodes. They include several forms of myeloma, leukemia, and lymphoma. According to an industry report in 2011, Hematological malignancies constituted 9% of all newly diagnosed malignancies in the U.S. specifying that lymphomas are more prevalent than myeloma or leukemias. Excluding Hodgkin’s lymphoma as well as acute lymphocytic leukemia, these types of malignancy are usually related to growing age. Hence, considering the aging worldwide population, malignancy type is more probable to become more prevalent.


The global Hematologic Malignancies Therapeutics Market growth is majorly driven by the increasing focus on development for novel treatments and growing occurrence of blood cancer. Currently, blood malignancies are the second most leading cause of cancer deaths and the 5th most common cancer. The three most common types of blood cancers are multiple myeloma leukemia, and lymphoma. Each year, approximately 400,000 people are diagnosed with lymphoma and more than 300,000 people are diagnosed with leukemia globally. In addition, inventions of novel drugs for blood cancer and its regulatory approvals are anticipated to bolster the market growth. For instance, in 2015, Pfizer announced that its antibody-drug conjugate- inotuzumab has received USFDA approval for acute lymphoblastic leukemia.  

The Global Hematologic Malignancies Therapeutics Market is segmented on the basis of type, therapy, and geography. Based on type, the market is segmented into leukemia, lymphoma, multiple myeloma, and others. The leukemia is further segmented into acute lymphocytic leukemia, chronic lymphocytic leukemia, acute myeloid leukemia, and chronic myeloid leukemia. On the basis of type, leukemia was estimated to dominate the market. The major market share is due to availability of products such as Imbruvica, Rituxan, and Glivec, which are estimated to be the highest revenue generating drugs. On the basis of therapy, the global Hematologic Malignancies Therapeutics Market is segmented into Chemotherapy, Radiotherapy, Immunotherapy, Stem Cell Transplantation, and Others. Amongst all the therapies, chemotherapy is the most commonly used treatment with a particular drug or combination of drugs used.
  

On the basis of region, the global Hematologic Malignancies Therapeutics Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America was estimated to dominate the global market. The dominance is majorly attributed to the high presence of key market players, availability of branded drugs, established healthcare organization, and increasing government support in the region. However, Asia Pacific is expected to dominate the global market during the forecast period. Increasing awareness about early diagnosis, availability of effective treatment in emerging countries, such as India and China, growing healthcare expenditure, and high unmet clinical needs of patients, are some of the factors anticipated to significantly boost the market in the Asia Pacific.

Some major key players in global Hematologic Malignancies Therapeutics Market includes Pfizer, Inc., F. Hoffmann-LA Roche ltd, Sanofi-Aventis, Bristol-Myers Squibb Company, AbbVie, Inc., Novartis AG, GlaxoSmithKline PLC, Celgene Corporation, Johnson & Johnson Services, Inc., and Takeda Pharmaceutical Company limited among others. The object of the key market players is to deliver better chronic care administration while keeping the cost low. In addition, the companies are concentrating on producing easy-to-use monitoring devices that can aid patients to accomplish conditions including diabetes or heart diseases better by avoiding costly medical processes.


Contact us
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com
on No comments:
Labels: , ,
Subscribe to: Posts (Atom)